Immunohistochemical staining revealed decreased PTEN and increased phosphorylated AKT expression in tumor tissues from patients with high-degree NSCLC (Figure 3h and i), highlighting the crucial role of PTEN/AKT signaling in NSCLC. The gene discussed is AKT1; the disease is neoplasm.